ArticleScientific reports2025
Using AI system to detect active tuberculosis in a high-prevalence setting on CT scans: a multi-center study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To evaluate the feasibility of an AI system for identifying active tuberculosis (ATB) in TB-specialized hospitals in high-prevalence settings. An AI system designed to identify ATB was retrospectively validated using a multi-center dataset of 1741 CT images from three TB-specialized hospitals. The dataset included ATB, pneumonia, pulmonary nodules and normal cases. The system's utility and generalizability were assessed across four application scenarios, and pairwise comparisons of the system's performance were conducted among the three hospitals. The system demonstrated good generalizability across three settings. It achieved an AUC over 0.9 for distinguishing between abnormal and normal, over 0.95 for distinguishing between ATB and normal, over 0.8 for distinguishing between ATB and non-ATB, and an AUC ranging from 0.762 to 0.906 for distinguishing between ATB and other abnormalities (pneumonia and pulmonary nodules). For all evaluation matrices, at least one pairwise comparison showed no significant difference in performance among the three hospitals across different scenarios. Using an AI system to identify ATB in CT images is feasible in TB-specialized hospitals. This evaluation provides valuable insights for those looking to implement AI to support clinical decision-making and optimize resource utilization in hospitals overwhelmed by TB cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.